Alector, Inc. Reports Exit and Disposal Costs

Ticker: ALEC · Form: 8-K · Filed: 2025-03-10T00:00:00.000Z

Sentiment: neutral

Topics: restructuring, disposal, operations

TL;DR

Alector's filing indicates costs related to exiting or disposing of assets/operations.

AI Summary

On March 7, 2025, Alector, Inc. filed an 8-K report detailing cost associated with exit or disposal activities. The filing does not specify the exact dollar amount or nature of these costs, but indicates they are related to the company's operational restructuring or divestitures.

Why It Matters

This filing signals potential restructuring or divestment activities within Alector, which could impact future operations and financial performance.

Risk Assessment

Risk Level: medium — The filing indicates costs associated with exit or disposal activities, which can signal financial strain or strategic shifts that carry inherent risks.

Key Players & Entities

FAQ

What specific activities are associated with the 'exit or disposal' costs reported by Alector, Inc.?

The filing does not specify the exact nature of the exit or disposal activities, only that costs are associated with them.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on March 7, 2025.

What is Alector, Inc.'s principal executive office address?

Alector, Inc.'s principal executive offices are located at 131 Oyster Point Blvd., Suite 600, South San Francisco, California, 94080.

What is Alector, Inc.'s telephone number?

Alector, Inc.'s telephone number is (415) 231-5660.

What is the SIC code for Alector, Inc.?

The Standard Industrial Classification (SIC) code for Alector, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

From the Filing

0001193125-25-050448.txt : 20250310 0001193125-25-050448.hdr.sgml : 20250310 20250310090107 ACCESSION NUMBER: 0001193125-25-050448 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250307 ITEM INFORMATION: Cost Associated with Exit or Disposal Activities FILED AS OF DATE: 20250310 DATE AS OF CHANGE: 20250310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822933343 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38792 FILM NUMBER: 25722350 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 8-K 1 d890669d8k.htm 8-K 8-K false 0001653087 0001653087 2025-03-07 2025-03-07     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2025     Alector, Inc. (Exact name of Registrant as Specified in Its Charter)       Delaware   001-38792   82-2933343 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.) 131 Oyster Point Blvd. Suite 600   South San Francisco , California     94080 (Address of Principal Executive Offices)     (Zip Code) Registrant’s Telephone Number, Including Area Code: (415) 231-5660   (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock   ALEC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 2.05 Costs Associated with Exit or Disposal Activities. On March 7, 2025, Alector, Inc. (“Alector” or “the Company”) committed to a plan to reduce its workforce (the “Plan”) by approximately 13% as part of its cost reduction initiatives in order to align resources with the Company’s strategic priorities, including advancing its preclinical and research pipeline. The Company initiated a reduction in force impacting approximately 25 employees across the organization. The Company continues to expect that its existing cash, cash equivalents and inves

View on Read The Filing